Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis
ConditionPlanter Fasciitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorBangladesh Medical University
About this trial
This randomized controlled trial evaluates the comparative effectiveness of platelet-rich plasma (PRP) therapy and prolotherapy in patients with plantar fasciitis. Both interventions are commonly used regenerative injection therapies intended to improve pain and functional outcomes in patients who do not respond adequately to conventional conservative treatments.
Participants diagnosed with plantar fasciitis will be randomly assigned to receive either PRP injection or prolotherapy. The results of this study aim to identify the more effective injection therapy for improving clinical outcomes in patients with plantar fasciitis
Eligibility criteria
Qualifiers
Patient with plantar fasciitis not responding to conservative therapy.
Disqualifiers
Patients with uncontrolled diabetes, haematological disorders, hepatitis B or C, HIV, clinical signs of acute inflammation, or septicaemia.
Those receiving local steroid injections within one month.
Those receiving non-steroidal anti-inflammatory medications within 72 hours.
Platelet levels 25% below the normal level.
Trial design
Treatments tested in this trial
- platelet-rich plasma injection
- Prolotherapy with 25% Dextrose
Treatment groups
68 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov